BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28980104)

  • 1. Experiences of a High-Risk Population with Prenatal Hemoglobinopathy Carrier Screening in a Primary Care Setting: a Qualitative Study.
    Holtkamp KCA; Lakeman P; Hader H; Jans SMJP; Hoenderdos M; Playfair HAM; Cornel MC; Peters M; Henneman L
    J Genet Couns; 2018 Jun; 27(3):635-646. PubMed ID: 28980104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier screening for thalassemia and hemoglobinopathies in Canada.
    Langlois S; Ford JC; Chitayat D; ;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study.
    Crombag NM; Boeije H; Iedema-Kuiper R; Schielen PC; Visser GH; Bensing JM
    BMC Pregnancy Childbirth; 2016 May; 16(1):121. PubMed ID: 27229318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'A morass of considerations': exploring attitudes towards ethnicity-based haemoglobinopathy-carrier screening in primary care.
    Jans SM; Henneman L; de Jonge A; van El CG; van Tuyl LH; Cornel MC; Lagro-Janssen AL
    Fam Pract; 2013 Oct; 30(5):604-10. PubMed ID: 23629736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: a pilot study.
    Giordano PC; Plancke A; Van Meir CA; Janssen CA; Kok PJ; Van Rooijen-Nijdam IH; Tanis BC; van Huisseling JC; Versteegh FG
    Prenat Diagn; 2006 Aug; 26(8):719-24. PubMed ID: 16752436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turkish female immigrants' intentions to participate in preconception carrier screening for hemoglobinopathies in the Netherlands: an empirical study.
    van Elderen T; Mutlu D; Karstanje J; Passchier J; Tibben A; Duivenvoorden HJ
    Public Health Genomics; 2010; 13(7-8):415-23. PubMed ID: 20805680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal hemoglobinopathy screening. IV. Follow-up of women at risk for a child with a clinically significant hemoglobinopathy.
    Loader S; Sutera CJ; Segelman SG; Kozyra A; Rowley PT
    Am J Hum Genet; 1991 Dec; 49(6):1292-9. PubMed ID: 1746556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of nonselective testing for hemoglobinopathies in early pregnancy in The Netherlands.
    Kaufmann JO; Demirel-Güngör G; Selles A; Hudig C; Steen G; Ponjee G; Holleboom C; Freeman LM; Hendiks J; Wijermans P; Giordano PC; Kerkhoffs JL
    Prenat Diagn; 2011 Dec; 31(13):1259-63. PubMed ID: 22031467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobinopathy screening in primary care in the Netherlands: exploring the problems and needs of patients and general practitioners.
    van Vliet ME; Kerkhoffs JH; Harteveld CL; Houwink EJF
    Eur J Hum Genet; 2023 Apr; 31(4):417-423. PubMed ID: 35945245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The provision of information and informed decision-making on prenatal screening for Down syndrome: a questionnaire- and register-based survey in a non-selected population.
    Schoonen M; Wildschut H; Essink-Bot ML; Peters I; Steegers E; de Koning H
    Patient Educ Couns; 2012 Jun; 87(3):351-9. PubMed ID: 22030253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring health education with midwives, as perceived by pregnant women in primary care: A qualitative study in the Netherlands.
    Baron R; Heesterbeek Q; Manniën J; Hutton EK; Brug J; Westerman MJ
    Midwifery; 2017 Mar; 46():37-44. PubMed ID: 28161688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The attitudes and intention to participate in hemoglobinopathy carrier screening in The Netherlands among individuals from Turkish, Moroccan, and Surinamese descent.
    van der Pal SM; van Kesteren NM; van Wouwe JP; van Dommelen P; Detmar SB
    J Environ Public Health; 2013; 2013():374831. PubMed ID: 24348582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative investigation of alcohol use advice during pregnancy: experiences of Dutch midwives, pregnant women and their partners.
    van der Wulp NY; Hoving C; de Vries H
    Midwifery; 2013 Nov; 29(11):e89-98. PubMed ID: 23434309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing prenatal and neonatal diagnosis of hemoglobinopathies.
    Schoen EJ; Marks SM; Clemons MM; Bachman RP
    Pediatrics; 1993 Sep; 92(3):354-7. PubMed ID: 8361789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do pregnant women benefit from hemoglobinopathy carrier detection?
    Rowley PT; Loader S; Sutera CJ; Walden M
    Ann N Y Acad Sci; 1989; 565():152-60. PubMed ID: 2774422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal screening for hemoglobinopathies. I. A prospective regional trial.
    Rowley PT; Loader S; Sutera CJ; Walden M; Kozyra A
    Am J Hum Genet; 1991 Mar; 48(3):439-46. PubMed ID: 1998330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes of general practitioners and midwives towards ethnicity-based haemoglobinopathy-carrier screening.
    Jans SM; de Jonge A; Henneman L; Cornel MC; Lagro-Janssen AL
    Eur J Hum Genet; 2012 Nov; 20(11):1112-7. PubMed ID: 22549405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.
    Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R
    J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.